3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
152
Lymphoma, Mantle-Cell
30
Lymphoma, Non-Hodgkin
22
Lymphoma, Follicular
22
Lymphoma
22
Recurrence
21
Neoplasms, Plasma Cell
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia, Myeloid, Acute
12
Waldenstrom Macroglobulinemia
11
Lymphoma, Large B-Cell, Diffuse
11
Immunoglobulin Light-chain Amyloidosis
10
Neoplasms
8
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma, B-Cell
7
Leukemia
6
Carcinoma, Non-Small-Cell Lung
6
Myelodysplastic Syndromes
5
Hematologic Neoplasms
5
Brain Neoplasms
5
Amyloidosis
5
Lymphoma, Large-Cell, Immunoblastic
4
Hematologic Diseases
4
Congenital Abnormalities
4
Prostatic Neoplasms
3
Paraproteinemias
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Monocytic, Acute
3
Leukemia, Erythroblastic, Acute
3
Interventions
Pemetrexed
12
Cisplatin
11
pembrolizumab
8
Carboplatin
6
Ipilimumab
5
Nivolumab
4
LMB-100
4
durvalumab
3
Gemcitabine
3
tremelimumab
2
tazemetostat
2
anetumab ravtansine
2
Vinorelbine
2
Plicamycin
2
Dexamethasone
2
Cyclophosphamide
2
Bevacizumab
2
vandetanib
1
tocilizumab
1
spartalizumab
1
ribociclib
1
rebastinib
1
pevonedistat
1
olaparib
1
niraparib
1
nintedanib
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
enzalutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mesothelioma
×
Bortezomib
×
Clear all
No trials found.